SunOpta CHRO receives 24.8k RSU award, Form 4 filed

Rhea-AI Filing Summary

SunOpta Inc. (STKL) – Form 4 insider filing

On 10 July 2025, Chief Human Resources Officer Danielle M. Duzan was granted 24,834 Restricted Stock Units (RSUs). Each RSU represents the contingent right to receive one common share of SunOpta.

• Transaction code: A (award/grant)
• Exercise price: $0.00 (RSUs carry no purchase cost)
• Vesting schedule: three equal annual tranches starting 10 July 2026; full vesting in 2028, subject to continued employment
• Ownership after grant: 24,834 common shares held directly (no indirect holdings reported)

No derivative expiration date is applicable because RSUs convert automatically upon vesting. The filing does not indicate any sale or disposition of shares, and no additional cash compensation details are provided.

For investors, the award modestly increases upcoming share count through future issuance but also aligns the CHRO’s incentives with shareholder interests.

Positive

• Insider acquisition rather than sale reinforces confidence and aligns management with shareholders.
• Three-year vesting schedule promotes executive retention and long-term focus.

Negative

• Share dilution: future issuance of 24,834 shares will marginally increase the outstanding share count.

Insights

Equity Compensation Analyst

TL;DR – Minor RSU grant aligns CHRO with shareholders; immaterial dilution.

The 24,834-unit RSU award to SunOpta’s CHRO is routine executive compensation. At a sub-$1 million notional value (assuming a share price in single digits), the grant is unlikely to materially affect the company’s share count or earnings dilution when amortized. Nonetheless, it reinforces long-term retention through a three-year vesting cliff, a structure typical for management incentives. Because the transaction is an acquisition rather than a disposal, it avoids the negative signal often associated with insider selling. Overall impact on valuation or near-term trading is minimal.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Duzan Danielle Marie

(Last) (First) (Middle)

7078 SHADY OAK ROAD

(Street)

EDEN PRAIRIE MN 55344

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
SunOpta Inc. [ STKL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CHRO

3. Date of Earliest Transaction (Month/Day/Year)
07/10/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(1)	07/10/2025		A		24,834		(3)	(2)	Common Shares	24,834	$0.00	24,834	D

Explanation of Responses:

1. Each Restricted Stock Unit represents a contingent right to receive one share of STKL common stock.

2. The Restricted Stock Units do not have an expiration date.

3. The Restricted Stock Units vest in three equal annual installments beginning on July 10, 2026, subject to the continued employment of the reporting person through each such vesting date.

	/s/ Brett Koch, attorney-in-fact	07/14/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many shares did SunOpta's CHRO acquire according to the Form 4?

The filing shows an award of 24,834 Restricted Stock Units, each convertible into one common share.

What is the vesting schedule for the 24,834 RSUs granted to STKL's CHRO?

The RSUs vest in three equal annual installments beginning on 10 July 2026 and fully vest by 2028.

Does the RSU grant to Danielle Duzan have an exercise price?

No. RSUs are granted at $0.00 exercise price; shares are delivered upon vesting without cash payment.

Will the RSU award dilute existing SunOpta shareholders?

Yes, issuance of 24,834 new shares upon vesting will cause minor dilution, but the amount is immaterial relative to total shares outstanding.

Did the Form 4 report any insider sales of STKL stock?

No. The filing records an acquisition (code “A”) of RSUs; no shares were sold or disposed.